Trial intelligence / Profile preview

Pidrolax versus Pidrolax + Laxa Plus for pediatric functional constipation

IRCT20201029049185N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of macrogol 4000 in functional constipation (FC) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Constipation treatment. Started Nov 2019; status: completed.

02

Drugs

macrogol 4000
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on IRCT20201029049185N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201029049185N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call